Esta tradução está a ser preparada. Entretanto, mostramos temporariamente a versão original em inglês.
Negócios · 19/12/20121 min de leitura
Impact of Approved Drug Labeling on Chronic Opioid Therapy; Public Hearing; Request for Comments
Tradução automática local · Idioma original da fonte
Resumo
The Food and Drug Administration (FDA) is announcing a public hearing to obtain information, particularly scientific evidence, such as study data or peer-reviewed analyses, on issues pertaining to the use of opioid drugs in the treatment of chronic pain.
Idioma original da fonte: Federal Register — Food and Drug AdministrationAbrir o comunicado original →